Hoeschele, 2009, Dalton Trans., 10648
Kelland, 2007, Nat. Rev. Cancer, 7, 573, 10.1038/nrc2167
Puckett, 2010, Dalton Trans., 39, 1159, 10.1039/B922209J
Jamieson, 1999, Chem. Rev., 99, 2467, 10.1021/cr980421n
Chapman, 2010, J. Am. Chem. Soc., 132, 1946, 10.1021/ja908419j
Piccart, 2001, Ann. Oncol., 12, 1195, 10.1023/A:1012259625746
Kehe, 2005, Toxicology, 214, 198, 10.1016/j.tox.2005.06.014
Neidle, 1980, J. Inorg. Biochem., 13, 205, 10.1016/S0162-0134(00)80069-0
Frey, 1993, Inorg. Chem., 32, 1333, 10.1021/ic00060a005
Laurie, 2010, Cancer, 116, 362, 10.1002/cncr.24745
Penson, 2010, J. Clin. Oncol., 28, 154, 10.1200/JCO.2009.22.7900
Boulikas, 2003, Oncol. Rep., 10, 1663
Kasparkova, 2008, Chem.–Eur. J., 14, 1330, 10.1002/chem.200701352
Lordick, 2010, Br. J. Cancer, 102, 500, 10.1038/sj.bjc.6605521
Zarate, 2010, Br. J. Cancer, 102, 987, 10.1038/sj.bjc.6605595
Kuwahara, 2009, Int. J. Med. Sci., 6, 305, 10.7150/ijms.6.305
Alberto, 2009, J. Phys. Chem. B, 113, 14473, 10.1021/jp9056835
Kawai, 2005, Biol. Pharm. Bull., 28, 1385, 10.1248/bpb.28.1385
Boulikas, 2007, Cancer Ther., 5, 537
Kodaira, 2006, Anticancer Res., 26, 2265
Kurita, 2010, Cancer Chemother. Pharmacol., 65, 503, 10.1007/s00280-009-1056-z
Gong, 2009, Cancer Chemother. Pharmacol., 64, 327, 10.1007/s00280-008-0874-8
Oshita, 2004, J. Exp. Ther. Oncol., 4, 343
Yamashita, 2006, Dis. Esophagus., 19, 15, 10.1111/j.1442-2050.2006.00531.x
Zheng, 2010, Jpn. J. Clin. Oncol., 40, 425, 10.1093/jjco/hyp183
Mross, 1992, Onkologie, 15, 139
Gietema, 1993, Anti-Cancer Drugs, 4, 51, 10.1097/00001813-199302000-00007
Gietema, 1995, Br. J. Cancer, 71, 1302, 10.1038/bjc.1995.252
Kavanagh, 1995, Gynecol. Oncol., 58, 106, 10.1006/gyno.1995.1191
Degardin, 1995, Invest. New Drugs, 13, 253, 10.1007/BF00873809
Welink, 1999, Clin. Cancer Res., 5, 2349
Gietema, 1993, Br. J. Cancer, 67, 396, 10.1038/bjc.1993.73
Manegold, 1996, Onkologie, 19, 248
Ma, 2009, Linchuang Zhongliuxue Zazhi, 14, 816
Sternberg, 1997, Ann. Oncol., 8, 695, 10.1023/A:1008269432176
Limited, 2003, Drugs R&D, 4, 369, 10.2165/00126839-200304060-00008
Shi, 2008, Xiandai Zhongxiyi Jiehe Zazhi, 17, 5105
Shchepinov, 2001, Nucleic Acids Res., 29, 3864, 10.1093/nar/29.18.3864
Kim, 1994, J. Med. Chem., 37, 1471, 10.1021/jm00036a013
Kim, 1995, Cancer Chemother. Pharmacol., 37, 1, 10.1007/BF00685622
Kim, 1995, Cancer Chemother. Pharmacol., 35, 441, 10.1007/s002800050260
Lee, 2006, Anti-Cancer Drugs, 17, 377, 10.1097/01.cad.0000205033.08838.c7
Kim, 2001, Cancer, 91, 1549, 10.1002/1097-0142(20010415)91:8<1549::AID-CNCR1164>3.0.CO;2-2
Lee, 2005, Cancer Res. Treat., 37, 208, 10.4143/crt.2005.37.4.208
Oh, 2003, Cancer Res. Treat., 35, 117, 10.4143/crt.2003.35.2.117
Kim, 1999, Cancer, 86, 1109, 10.1002/(SICI)1097-0142(19991001)86:7<1109::AID-CNCR3>3.0.CO;2-G
Min, 2004, J. Korean Med. Sci., 19, 369, 10.3346/jkms.2004.19.3.369
Ahn, 2002, Cancer Chemother. Pharmacol., 50, 104, 10.1007/s00280-002-0483-x
Lee, 2009, Cancer Res. Treat., 41, 12, 10.4143/crt.2009.41.1.12
Ohstu, 2003, J. Clin. Oncol., 21, 54, 10.1200/JCO.2003.04.130
Braddock, 1975, Chem.-Biol. Interact., 11, 145, 10.1016/0009-2797(75)90095-2
Connors, 1972, Chem.-Biol. Interact., 5, 415, 10.1016/0009-2797(72)90078-6
Connors, 1975, FEBS Lett., 57, 223, 10.1016/0014-5793(75)80305-X
Owens, 1985, Cancer Chemother. Pharmacol., 14, 253, 10.1007/BF00258128
Thatcher, 1982, Cancer Chemother. Pharmacol., 9, 13, 10.1007/BF00296754
Hill, 1982, Anticancer Res., 2, 173
Boulikas, 2007, Cancer Ther., 5, 537
Gibbons, 1989, Cancer Res., 49, 1402
Anderson, 1986, Cancer Treat. Rep., 70, 997
Rose, 1982, Cancer Treat. Rep., 66, 135
Rahman, 1988, Cancer Res., 48, 1745
Parker, 1993, Cancer Res., 53, 242
Schilder, 1994, Cancer Res., 54, 709
Tutsch, 1999, Invest. New Drugs, 17, 63, 10.1023/A:1006223100561
O'Rourke, 1994, Anti-Cancer Drugs, 5, 520, 10.1097/00001813-199410000-00002
O'Brien, 1992, Cancer Res., 52, 4130
Kobayahi, 1991, Invest. New Drugs, 9, 313, 10.1007/BF00183571
Elliott, 1994, Cancer Res., 54, 4412
Perez, 1991, Int. J. Cancer, 48, 265, 10.1002/ijc.2910480219
Takahashi, 1993, Cancer Chemother. Pharmacol., 33, 31, 10.1007/BF00686019
Takahashi, 1996, Oncology, 53, 68, 10.1159/000227538
O'Dwyer, 1992, Cancer Res., 52, 6746
Theriault, 1993, Cancer Chemother. Pharmacol., 31, 333, 10.1007/BF00685681
Theriault, 1996, Cancer Chemother. Pharmacol., 38, 289, 10.1007/s002800050484
Bitha, 1989, J. Med. Chem., 32, 2015, 10.1021/jm00128a052
Meijer, 1992, Cancer Res., 52, 6885
Kelland, 1992, Plat. Met. Rev., 36, 178, 10.1595/003214092X364178184
Kudelka, 1997, Anti-Cancer Drugs, 8, 649, 10.1097/00001813-199708000-00001
Dodion, 1991, Ann. Oncol., 2, 589, 10.1093/oxfordjournals.annonc.a058026
Willemse, 1991, Proc. Am. Assoc. Clin. Oncol., 10, 191
Markman, 1993, J. Cancer Res. Clin. Oncol., 119, 234, 10.1007/BF01624436
Piccart, 1991, Proc. Am. Assoc. Cancer Res., 32, 1222
Aamdal, 1997, Cancer Chemother. Pharmacol., 40, 439, 10.1007/s002800050683
Olver, 1995, Am. J. Clin. Oncol., 18, 56, 10.1097/00000421-199502000-00012
Jones, 1991, Br. J. Cancer, 63, 7
Tanis, 1991, Eur. J. Cancer Clin. Oncol., 27, 268, 10.1016/0277-5379(91)90513-D
Sørensen, 1985, Cancer Chemother. Pharmacol., 15, 97, 10.1007/BF00257516
Colombo, 1986, Cancer Treat. Rep., 70, 793
Tanis, 1992, Oncology, 49, 99, 10.1159/000227020
Drees, 1995, Eur. J. Cancer, 31, 356, 10.1016/0959-8049(94)00513-5
Bagrova, 2001, Voprosy Onkologii, 47, 752
Akamatsu, 1992, Br. J. Cancer, 66, 827, 10.1038/bjc.1992.368
Lebwohl, 1998, Eur. J. Cancer, 34, 1522, 10.1016/S0959-8049(98)00224-X
Kobayashi, 1991, Invest. New Drugs, 9, 313, 10.1007/BF00183571
Tamura, 1990, Cancer, 66, 2059, 10.1002/1097-0142(19901115)66:10<2059::AID-CNCR2820661003>3.0.CO;2-#
Aoyama, 1992, Cancer Chemother., 19, 1033
Kato, 1992, Cancer Chemother., 19, 1285
Pendyala, 1988, Cancer Res, 48, 3533
Bramwell, 1985, Cancer Treat. Rep., 69, 409
Paolozzi, 1988, Invest. New Drugs, 6, 199, 10.1007/BF00175398
Chawla, 1988, Invest. New Drugs, 6, 311, 10.1007/BF00173650
Sessa, 1988, J. Clin. Oncol., 6, 98, 10.1200/JCO.1988.6.1.98
de Wit, 1991, Eur. J. Cancer Clin. Oncol., 27, 1383, 10.1016/0277-5379(91)90015-6
Cantwell, 1986, Cancer Chemother. Pharmacol., 18, 286, 10.1007/BF00273405
Hortobagyi, 1987, Cancer Treat. Rep., 71, 1193
Vermorken, 1993, Ann. Oncol., 4, 303, 10.1093/annonc/4.suppl_4.S41
Casper, 1988, Invest. New Drugs, 6, 87, 10.1007/BF00195365
Meisner, 1989, Am. J. Clin. Oncol., 12, 129, 10.1097/00000421-198904000-00008
Nitschke, 1992, Invest. New Drugs, 10, 93, 10.1007/BF00873123
Castleberry, 1994, J. Clin. Oncol., 12, 1616, 10.1200/JCO.1994.12.8.1616
Friedman, 1992, J. Clin. Oncol., 10, 249, 10.1200/JCO.1992.10.2.249
Drasga, 1987, Cancer Treat. Rep., 71, 863
Murphy, 1992, Invest. New Drugs, 10, 327, 10.1007/BF00944190
Goldenberg, 1990, Invest. NewDrugs, 8, 71
Petrelli, 1989, Cancer Chemother. Pharmacol., 23, 61
Asbury, 1989, Am. J. Clin. Oncol., 12, 416, 10.1097/00000421-198910000-00011
Blitzer, 1988, Am. J. Clin. Oncol., 11, 650, 10.1097/00000421-198812000-00012
McGuire, 1986, Invest. New Drugs, 4, 181, 10.1007/BF00194600
Lira-Peurto, 1991, Cancer Chemother. Pharmacol., 28, 391, 10.1007/BF00685695
Kramer, 1988, Am. J. Clin. Oncol., 11, 643, 10.1097/00000421-198812000-00010
Granfortuna, 1989, Am. J. Clin. Oncol., 12, 355, 10.1097/00000421-198908000-00016
Abele, 1987, Eur. J. Cancer Clin. Oncol., 23, 387, 10.1016/0277-5379(87)90374-9
Clavel, 1988, Eur. J. Cancer Clin. Oncol., 24, 1345, 10.1016/0277-5379(88)90226-X
Anderson, 1988, Eur. J. Cancer Clin. Oncol., 24, 1471, 10.1016/0277-5379(88)90338-0
Saito, 1995, ORL, 57, 250, 10.1159/000276752
White, 2006, Br. J. Cancer, 95, 822, 10.1038/sj.bjc.6603345
Bandak, 1999, Anti-Cancer Drugs, 10, 911, 10.1097/00001813-199911000-00007
Newman, 1999, Cancer Chemother. Pharmacol., 43, 1, 10.1007/s002800050855
Working, 1998, Toxicol. Sci., 46, 155
Vaage, 1999, Int. J. Cancer, 80, 134, 10.1002/(SICI)1097-0215(19990105)80:1<134::AID-IJC24>3.0.CO;2-Q
Harrington, 2001, Ann. Oncol., 12, 493, 10.1023/A:1011199028318
Veal, 2001, Br. J. Cancer, 84, 1029, 10.1054/bjoc.2001.1723
Terwogt, 2002, Cancer Chemother. Pharmacol., 49, 201, 10.1007/s002800100371
Liu, 2001, Proc. Am. Soc. Clin. Oncol., 20
Rosenthal, 2002, Invest. New Drugs, 20, 343, 10.1023/A:1016201732368
Vokes, 2000, Clin. Lung Cancer, 2, 128, 10.3816/CLC.2000.n.025
Kim, 2001, Lung Cancer, 34, 427, 10.1016/S0169-5002(01)00278-1
Vail, 2002, Cancer Chemother. Pharmacol., 50, 131, 10.1007/s00280-002-0469-8
Schroeder, 2007, Langmuir, 23, 4019, 10.1021/la0631668
Schroeder, 2009, J. Controlled Release, 137, 63, 10.1016/j.jconrel.2009.03.007
Lauterzstain, 1986, Cancer Chemother. Pharmacol., 18, 93, 10.1007/BF00253076
Perez-Soler, 1988, CancerRes., 48, 4509
Khokhar, 1991, J. Med. Chem., 34, 325, 10.1021/jm00105a051
Perez-Soler, 1989, Cancer Chemother. Pharmacol., 24, 1, 10.1007/BF00254097
Han, 1993, Cancer Res., 53, 4913
Han, 1996, Cancer Chemother. Pharmacol., 39, 17, 10.1007/s002800050533
Han, 1994, Anti-Cancer Drugs, 5, 64, 10.1097/00001813-199402000-00010
Perez-Soler, 1987, Cancer Res., 47, 6462
Perez-Soler, 1990, Cancer Res., 50, 4254
Dragovich, 2006, Cancer Chemother. Pharmacol., 58, 759, 10.1007/s00280-006-0235-4
Rothenberg, 2003, J. Clin. Oncol., 21, 2059, 10.1200/JCO.2003.11.126
Perez-Soler, 1997, Clinical Cancer Res., 3, 373
Lu, 2005, J. Clin. Oncol., 23, 3495, 10.1200/JCO.2005.00.802
Verschraegen, 2003, J. Cancer Res. Clin. Oncol., 129, 549, 10.1007/s00432-003-0481-3
Wheate, 2005, Curr. Med. Chem.: Anti-Cancer Agents, 5, 267
Di Blasi, 1998, Anticancer Res., 18, 3113
Roberts, 1999, J. Inorg. Biochem., 77, 47, 10.1016/S0162-0134(99)00137-3
Roberts, 1999, J. Inorg. Biochem., 77, 51, 10.1016/S0162-0134(99)00147-6
Perego, 1999, J. Inorg. Biochem., 77, 59, 10.1016/S0162-0134(99)00142-7
McGregor, 2002, JBIC, J. Biol. Inorg. Chem., 7, 397, 10.1007/s00775-001-0312-4
Kloster, 1999, Biochemistry, 38, 14731, 10.1021/bi991202e
Brabec, 1999, Biochemistry, 38, 6781, 10.1021/bi990124s
Kasparkova, 2002, J. Biol. Chem., 277, 48076, 10.1074/jbc.M208016200
Qu, 2003, JBIC, J. Biol. Inorg. Chem., 8, 19, 10.1007/s00775-002-0383-x
Qu, 2004, J. Inorg. Biochem., 98, 1585, 10.1016/j.jinorgbio.2004.07.011
Hegmans, 2004, J. Am. Chem. Soc., 126, 2166, 10.1021/ja036105u
Qu, 2009, JBIC, J. Biol. Inorg. Chem., 14, 969, 10.1007/s00775-009-0509-5
Ruhayel, 2009, Chem.–Eur. J., 15, 9365, 10.1002/chem.200900958
McGregor, 1999, J. Inorg. Biochem., 77, 43, 10.1016/S0162-0134(99)00136-1
McGregor, 2002, J. Inorg. Biochem., 91, 212, 10.1016/S0162-0134(02)00398-7
Komeda, 2006, J. Am. Chem. Soc., 128, 16092, 10.1021/ja062851y
Liu, 2006, Biochemistry, 45, 4248, 10.1021/bi052517z
Billecke, 2006, Neuro-Oncology, 8, 215, 10.1215/15228517-2006-004
Orlandi, 2001, Eur. J. Cancer, 37, 649, 10.1016/S0959-8049(00)00445-7
Riccardi, 2001, Cancer Chemother. Pharmacol., 47, 498, 10.1007/s002800000264
Colella, 2001, Br. J. Cancer, 84, 1387, 10.1054/bjoc.2001.1751
Servidei, 2001, Eur. J. Cancer, 37, 930, 10.1016/S0959-8049(01)00061-2
Manzotti, 2000, Clin. Cancer Res., 6, 2626
Perego, 1999, Mol. Pharm., 55, 528
Pratesi, 1999, Br. J. Cancer, 80, 1912, 10.1038/sj.bjc.6690620
Sessa, 2000, Ann. Oncol., 11, 977, 10.1023/A:1008302309734
Calvert, 2000, Proc. Am. Soc. Clin. Oncol, 19, abstr 921F
Jodrell, 2004, Eur. J. Cancer, 40, 1872, 10.1016/j.ejca.2004.04.032
Hensing, 2006, Anti-Cancer Drugs, 17, 697, 10.1097/01.cad.0000215054.62942.7f
Scagliotti, 2003, Lung Cancer, 41, S223, 10.1016/S0169-5002(03)92490-1
Calvert, 2001, Eur. J. Cancer, 37, S260, 10.1016/S0959-8049(01)81457-X
Kelland, 1993, Cancer Res., 53, 2581
Samimi, 2006, Cancer Chemother. Pharmacol., 57, 781, 10.1007/s00280-005-0121-5
Choy, 2008, Clin. Cancer Res., 14, 1633, 10.1158/1078-0432.CCR-07-2176
Fokkema, 2002, Biochem. Pharmacol., 63, 1989, 10.1016/S0006-2952(02)00983-8
Cmelak, 1999, Proc. Am. Soc. Clin. Oncol., 18
Holford, 1998, Anti-cancer Drug Des., 13, 1
Battle, 2006, Inorg. Chem., 45, 6317, 10.1021/ic060273g
Beale, 2003, Br. J. Cancer, 88, 1128, 10.1038/sj.bjc.6600854
Chen, 1998, Chem.–Eur. J., 4, 672, 10.1002/(SICI)1521-3765(19980416)4:4<672::AID-CHEM672>3.0.CO;2-8
Holford, 1998, Br. J. Cancer, 77, 366, 10.1038/bjc.1998.59
Sharp, 2002, Eur. J. Cancer, 38, 2309, 10.1016/S0959-8049(02)00244-7
Raynaud, 1997, Clin. Cancer Res., 3, 2063
Gelmon, 2003, Ann. Oncol., 14, 543, 10.1093/annonc/mdg171
Treat, 2002, Eur. J. Cancer, 38
Sood, 2006, Bioconjugate Chem., 17, 1270, 10.1021/bc0600517
Giansi, 1999, Eur. J. Cancer
Duncan, 1997, Chem. Ind., 7, 262
Rice, 2006, Clin. Cancer Res., 12, 2248, 10.1158/1078-0432.CCR-05-2169
Campone, 2007, Cancer Chemother. Pharmacol., 60, 523, 10.1007/s00280-006-0397-0
nowotnik, 2009, Adv.Drug Delivery Rev., 61, 1214, 10.1016/j.addr.2009.06.004
Viens, 2001, Eur. J. Cancer, 37, S323, 10.1016/S0959-8049(01)81689-0
Boulikas, 2004, Oncol. Rep., 12, 3
Boulikas, 2007, Cancer Ther., 5, 351
Stathopoulos, 2005, Oncol. Rep., 13, 589
Kwok, 2001, Annu. Rev. Genomics Hum. Genet., 2, 235, 10.1146/annurev.genom.2.1.235
Stathopoulos, 2006, Oncol. Rep., 15, 1201
Froudarakis, 2008, Cancer, 113, 2752, 10.1002/cncr.23921
Boulikas, 2005, Anticancer Res., 25, 3031
Ravaioli, 2009, J. Chemotherapy (Italy), 21, 86, 10.1179/joc.2009.21.1.86
Mylonakis, 2010, Lung Cancer, 68, 240, 10.1016/j.lungcan.2009.06.017
Kosmas, 2009, Eur. J. Cancer Suppl., 7, 531, 10.1016/S1359-6349(09)71801-4
Karpathiou, 2007, Oncology, 73, 426, 10.1159/000136800
Schildhauer, 2005, Eur. J. Cancer Suppl., 3, 286
Jehn, 2007, Oral Oncology Supplement, 2, 118, 10.1016/S1744-7895(07)70239-0
Koukourakis, 2010, Int. J. Radiat. Oncol., Biol., Phys., 10.1016/j.ijrobp.2009.07.1733